ResMed Inc.

ResMed Inc.

RSMDF

$22.61

Updated: 23/09/2026, 14:45:16

Market Cap
$43.79B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Stock valuation chart
One-year closing share-price history for RSMDF
Company Profile

ResMed Inc. is a leading global medical technology company specializing in the development, manufacturing, and distribution of medical devices and digital health solutions for the healthcare sector. Its operations are divided into two primary segments: Sleep and Respiratory Care, and Software as a Service (SaaS). The Sleep and Respiratory Care division offers a comprehensive range of products addressing various respiratory disorders. This includes advanced technologies for medical and consumer applications, ventilation devices, diagnostic tools, mask systems for both hospital and home use, headgear, other accessories, and dental devices. This segment also incorporates cloud-based informatics software designed to improve patient outcomes. Specific digital health offerings include AirView, a cloud-based system enabling remote monitoring and adjustment of patient device settings; myAir, a personalized therapy management application for sleep apnea patients providing support, education, and troubleshooting; and U-Sleep, a compliance monitoring solution that helps home medical equipment (HME) providers optimize their sleep programs. Additionally, ResMed offers connectivity modules, Propeller solutions, and the Propeller portal. Through its Software as a Service segment, ResMed delivers a suite of out-of-hospital software solutions. These comprise Brightree, a business management software and service platform for providers of HME, pharmacy, home infusion, orthotics, and prosthetics; MatrixCare, which offers comprehensive care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, alongside related accountable care organizations; and HEALTHCAREfirst, providing electronic health record (EHR) software, billing and coding services, and analytics for home health and hospice agencies. ResMed markets its extensive product line to sleep clinics, home healthcare dealers, and hospitals. The company utilizes a network of distributors and a direct sales force to reach customers in approximately 140 countries globally. Founded in 1989, ResMed Inc. maintains its headquarters in San Diego, California.

USD
OTC
CEO: Michael J. Farrell
Employees: 11,370
https://www.resmed.com
Asset Summaries
Latest generated summaries for RSMDF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for RSMDF.
Share price
$22.61
Market cap
$43.79B
Exchange
OTC
Currency
USD
CEO
Michael J. Farrell
Employees
11,370
IPO date
13/03/2013
Beta
0.748
Last dividend
$0.00
Day range
$22.48 – $22.61
52-week range
$11.85 – $28.25
1-day performance
0.00%
1-year performance
90.80%
Current drawdown (1Y)
-19.96%
CIK
0000943819
CUSIP
N/A
ISIN
AU000000RMD6
Created
07/12/2025, 14:03:34
Last update
23/09/2026, 14:45:16

Track ResMed Inc. with an AI analyst

See which prediction-market events move RSMDF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to RSMDF from your Railway `news_articles` table.

No news found for this symbol.